MIRA INFORM REPORT

 

 

Report Date :

27.10.2012

 

IDENTIFICATION DETAILS

 

Name :

EMBRAFARMA PRODUTOS QUIMICOS E FARMACEUTICOS LTDA

 

 

Registered Office :

Rua Carlo Carra, 66 Sala 02 - Vila Santa Catarina 04367-000 - São Paulo/Sp

 

 

 

 

Country :

Brazil

 

 

 

 

Financials (as on) :

31.12.2009

 

 

 

 

Date of Incorporation :

13.01.1992

 

 

 

 

Legal Form :

Limited Liability Company

 

 

 

 

Line of Business :

Wholesale, Import and Trade of Pharmaceutical Products.

 

 

 

 

No. of Employees :

26

 

 

RATING & COMMENTS

 

MIRA’s Rating :

C

 

RATING

STATUS

PROPOSED CREDIT LINE

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

 

Status :

Poor

Payment Behaviour :

--

Litigation :

Exist

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

BRAZIL - ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth to 2.7% for 2011 as a whole, though forecasts for 2012 growth are somewhat higher. Despite slower growth in 2011, Brazil overtook the United Kingdom as the world's seventh largest economy in terms of GDP. Urban unemployment is at the historic low of 4.7% (December 2011), and Brazil's traditionally high level of income equality has declined for each of the last 12 years. Brazil's high interest rates make it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchanges markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint.

Source : CIA


Company name

 

EMBRAFARMA PRODUTOS QUIMICOS E FARMACEUTICOS LTDA

 

 

ADDRESSES

 

MAIN ADDRESS:

RUA CARLO CARRA, 66 SALA 02 - VILA SANTA CATARINA

ZIP CODE/CITY:

04367-000 - SÃO PAULO/SP

 

 

PHONE:

11 2165-9275

FAX:

11 2165-9274

E-MAIL:

andrea@embrafarma.com.br

WEB SITE:

www.embrafarma.com.br

 

BRANCHES:

 

 

 

ADDRESS:

RUA CARLO GARRA, 74 - VILA SANTA CATARINA

ZIP CODE/CITY:

04370-000 SÃO PAULO/SP

 

 

ADDRESS:

RUA GOMES DE FREITAS, 491 SALA 201 - JARDIM ITÚ

ZIP CODE/CITY:

91380-000 PORTO ALEGRE/RS

 

 

ADDRESS:

RUA EMANOEL PEDRO FARIAS COSTA, 672 SALA 11 - CENTRO

ZIP CODE/CITY:

57017-070 MACEIÓ/AL

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

WHOLESALE, IMPORT AND TRADE OF PHARMACEUTICAL PRODUCTS.

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

13/01/1992

REGISTER DATE:

13/01/1992

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

67.422.600/0001-19

STATE REGISTER:

114.914.827.110

 

 

SHARE CAPITAL:

R$ 50.000,00

LAST REGISTER OF CAPITAL:

02/08/1999

 

BOARD OF DIRECTORS:

 

 

 

VALDIR MAGALHÃES DE OLIVEIRA

MANAGING PARTNER

EUGENIO GARRIDO JUNIOR

MANAGING PARTNER

 

AUTHORIZED USE OF SIGNATURE

 

THE MANAGING PARTNERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

VALDIR MAGALHÃES DE OLIVEIRA

50%

EUGENIO GARRIDO JUNIOR

50%

 

AFFILIATES / SUBSIDIARIES:

 

 

 

A SCAN THROUGH OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR PARTNERS HAVE THE FOLLOWING UNCONFIRMED HOLDINGS:

 

 

SYNTEC CHEMICALS REPRESENTAÇÃO COMERCIAL LTDA

 

GARRIDO PROMOÇÃO DE VENDAS E NEGÓCIOS LTDA

 

MAGAMARKETING ASSESSORIA E REPRESENTAÇÃO S/C LTDA

 

MAGA SERVIÇOS EMPRESARIAIS S/C LTDA

 

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON JANUARY 13, 1992 TO BE ENGAGED IN THE SAID LINE OF BUSINESS.

 

BUSINESS ADDRESS HAS CHANGED FROM (RUA GONÇALO DA COSTA, 54, SÃO PAULO/SP) TO THE PRESENT REGISTERED ONE.

 

PARTNERS:

 

VALDIR MAGALHÃES DE OLIVEIRA, BRAZILIAN, MARRIED, TRADER, HOLDER OF DOCUMENTS RG 5.996.285-9-SSP/SP AND CPF 444.170.478-04, DOMICILED RUA ADOLFO CASAIS MONTEIRO, 560, VILA NOVA CALEDONIA, ZIP CODE 04648-040, SÃO PAULO/SP;

 

EUGENIO GARRIDO JUNIOR, BRAZILIAN, DIVORCED, TRADER, HOLDER OF DOCUMENTS RG 15.486.219-8 SSP/SP AND CPF 065.414.048-01, DOMICILED RUA PRAIA DO CASTELO, 65, APTO 13-A, VILA MASCOTE, ZIP CODE 04648-001, SÃO PAULO/SP.

 

REMARKS:

 

THE DATA REGARDING THE SHARE CAPITAL OF BRL 1.000.000,00 AND CURRENT SHAREHOLDERS/PARNERS MRS LEONILDA FERRE MONZANI, MRS MARIA APARECIDA MONZANI ARE INACCURATE. THE INFORMATION HEREIN WAS EXTACTED FROM THE REGISTER OF COMPANIES, THEREFORE IS THE CORRECT ONE.

 

OUR DATA BASE SHOWS THAT THE COMPANY UNTIL NOVEMBER 2004 BELONGED TO THE SAME PARTNERS OF W QUIMICA E FARMACEUTICA LTDA COMPANY. MR EUGENIO GUARRIDO AND MR. VALDIR MAGALHAES DE OLIVEIRA WERE PARTNERS.

 

ON NOVEMBER 2004 MR VALDIR MAGALHAES DE OLIVEIRA LEFT THE COMPANY. OUR DATA BASE ALSO SHOWS THAT THE COMPANY HAS DEBITS OVER THAN USD 200.000,00 TO SEVERAL SUPPLIERS IN MANY COUNTRIES.

 

THE COMPANY THAT IS BEEN ANALYZED (EMBRAFARMA) HAS ALSO SOME DEBTS WITH A SUPPLIER IN A VALUE ABOUT USD 10.000,00.

 

IN A MEETING WITH MR VALDIR MAGALHAES OLIVEIRA, HE REPORTED THE COMPANIES DIDN'T HAVE MONEY TO PAY THE DEBITS AND W QUIMICA HAS A DEBT VALUE OF USD 600.000,00.

 

A DEAL WAS PURPOSED BY THE SUPPLIERS THAT THE COMPANY COULD CHARGE THE DEBT, BUT THE COMPANY DIDN'T WANT TO RECEIVE.

 

IN A CONTACT WITH EMBRAFARMA IN THE LAST DAYS, THEY REPORTED THAT BOTH, EMBRAFARMA AND W QUIMICA DON'T HAVE A RELATION ANYMORE, BUT THE DEBTS STILL EXIST.

 

FURTHER DETAILS ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

PROTESTS:

 

57  PROTESTS,TOTAL AMOUNT R$ 120.755,87

    DATE OF FIRST PROTEST: OCTOBER/2007  R$ 71,66

    DATE OF HIGHEST PROTEST: AUGUST/2012  R$ 9.000,00

 

DETAILS OF LATEST PROTESTS:

 

NOTARY OFFICE:

DATE:

VALUE:

3º CARTÓRIO DE SP-SÃO PAULO

02/10/2012

R$ 2.700,00

3º CARTÓRIO DE SP-SÃO PAULO

19/09/2012

R$ 3.940,00

6º CARTÓRIO DE SP-SÃO PAULO

19/09/2012

R$ 3.085,70

10º CARTÓRIO DE SP-SÃO PAULO

14/09/2012

R$ 1.535,73

1º CARTÓRIO DE SP-SÃO PAULO

12/09/2012

R$ 3.940,00

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

1

JUDICIAL RECOVERY ADJUDGED

27/07/07

1ª VARA DE SP-SP-CENTRAL

3

FEDERAL LAWSUITS

05/10/12

11ª VARA DE SP-SP-FEDERAL

2

STATE LAWSUITS

29/07/10

VARA DE SP-EXEC.FISC.EST.

1

MONITORY SUIT

15/01/08

2ª VARA DE SP-SP-JABAQUARA

 

 

PUBLIC INFORMATION:

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

1

JUDICIAL RECOVERY ADJUDGED

27/07/07

1ª VARA DE SP - SP - CENTRAL

 

JUDICIAL RECOVERY: ("RECUPERAÇÃO JUDICIAL" UNDER BRAZILIAN BANKRUPTCY LAW)

 

THE SUBJECT HAS FILED FOR JUDICIAL RECOVERY ON ABOVE MENTIONED DATE. JUDICIAL RECOVERY IS A VOLUNTARY PROCEEDING WHICH MAY BE ADOPTED BY COMPANIES WHICH ARE FACING FINANCIAL PROBLEMS AND NEED THE PROTECTION OF BRAZILIAN BANKRUPTCY LAW BENEFITS IN ORDER TO TRY TO IMPROVE THE FINANCIAL STANDING.

 

THE JUDICIAL RECOVERY UNDER BRAZILIAN BANKRUPTCY LAW IS SIMILAR TO THE PROCEEDINGS OF CHAPTER 11 OF USA BANKRUPTCY LAW.

 

THE COMPANY SUBJECT TO JUDICIAL RECOVERY IS REQUIRED TO PRESENT RECOVERY PLAN TO BE APPROVED BY THE MAJORITY OF ITS CREDITORS IN A GENERAL CREDITORS ASSEMBLY. PROVIDED THE RECOVERY PLAN IS APPROVED BY THE CREDITORS THE COURT GRANTS THE COMPANY THE RIGHTS OF OPERATING UNDER THE LAW PROTECTION AND A JUDICIAL ADMINISTRATOR IS APPOINTED TO SUPERVISE THE ACCOMPLISHING OF THE PAYMENT TERMS AND THE EXECUTION OF THE RECOVERY PLAN AS APPROVED.

 

THE JUDICIAL RECOVERY PROCEEDINGS ARE VERY EFFICIENT TO PROTECT THE COMPANIES AND TO GRANT THEM POSSIBILITIES TO RECOVERY FROM FINANCIAL PROBLEMS BUT THE APPROVAL OF THE CREDITORS AND IN-DEEP ACCOMPLISHMENT OF RECOVERY PLAN IS ESSENTIAL TO MAKE SURE THE COMPANY WILL KEEP THE LAW PROTECTION AS GRANTED BY THE COURT AND WILL BE SUCCESSFUL IN RECOVERING FROM THE FINANCIAL PROBLEMS WHICH LEAD IT TO REQUIRE THE JUDICIAL RECOVERY PROCEEDINGS PROTECTION.

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2009, 31/12/2008 AND 31/12/2007.

(FIGURES ARE IN REAIS).

 

ASSETS

 

 

 

CURRENT:

31/12/2009

31/12/2008

31/12/2007

 

 

 

 

CASH AND BANKS

30.172,81

63.009,06

-84,11

CLIENTS

1.052.004,10

929.560,25

459.354,02

RECOVERABLE TAXES

1.061,70

1.061,70

975,00

INVENTORY

985.042,48

638.347,28

595.115,68

ADVANCES

711.759,96

130.721,59

 

JUDICIAL DEPOSITS

52.240,73

8.393,35

 

PREPAID EXPENSES

5.009,14

4.895,02

 

TAX CREDITS

400,00

 

 

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

2.837.690,92

1.775.988,25

1.055.360,59

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

CONSORTIUM

2.915,96

2.100,00

2.100,00

LEASING

16.156,05

12.656,05

12.656,05

CREDIT WITH PARTNERS

 

193.691,91

 

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

19.072,01

208.447,96

14.756,05

 

FIXED ASSETS:

 

 

 

 

 

 

 

FIXED ASSETS

3.401.584,04

3.264.308,80

3.250.581,45

INVESTMENTS

6.485,79

6.485,79

 

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

3.408.069,83

3.270.794,59

3.250.581,45

 

================

================

================

TOTAL ASSETS

6.264.832,76

5.255.230,80

4.320.698,09

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2009

31/12/2008

31/12/2007

 

 

 

 

SUPPLIERS

821.299,20

821.368,27

82.983,92

LOANS AND FINANCING

226.561,25

372.395,48

 

TAXES & CONTRIBUTIONS

1.176.062,96

608.742,44

153.574,97

LABOR OBLIGATIONS

278.368,82

137.723,71

49.645,51

ACCOUNTS PAYABLE

4.866,59

4.911,43

 

LABOR PROVISIONS

44.556,11

10.524,08

 

ADVANCE FROM CLIENTS

9.691,30

 

 

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

2.561.406,23

1.955.665,41

286.204,40

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

94.072,24

 

468.372,15

TRIBUTARY OBLIGATIONS

1.480.090,06

1.564.375,12

746.606,49

PREFERRED CREDITORS

4.919.432,30

5.039.298,45

 

LOANS

473.760,17

 

 

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

6.967.354,77

6.603.673,57

1.214.978,64

 

DEFERRED INCOME

 

 

5.988.907,09

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

50.000,00

50.000,00

50.000,00

ACCRUED PROFIT (LOSS)

-4.139.922,87

-3.932.364,63

-3.915.426,72

RESOURCE/INCREASE CAPITAL

578.256,45

578.256,45

578.256,45

PROFIT RESERVES

247.738,18

 

 

PROFIT (LOSS) OF PERIOD

 

 

117.778,23

 

----------------

----------------

----------------

TOTAL NET EQUITY

-3.263.928,24

-3.304.108,18

-3.169.392,04

 

================

================

================

TOTAL LIABILITIES

6.264.832,76

5.255.230,80

4.320.698,09

 


 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2009, 31/12/2008 AND 31/12/2007.

(FIGURES ARE IN REAIS).

 

 

31/12/2009

31/12/2008

31/12/2007

 

 

 

 

GROSS SALES

 

6.997.923,62

2.097.890,23

(-) TAXES ON SALES

 

1.330.242,76

261.333,71

 

----------------

----------------

----------------

NET SALES

 

5.667.680,86

1.836.556,52

(-) COST OF SOLD GOODS

 

3.325.809,67

1.007.216,77

 

----------------

----------------

----------------

GROSS PROFIT

 

2.341.871,19

829.339,75

OPERATING REVENUE (EXPENSE)

 

-2.155.936,02

-685.305,74

FINANCIAL REVENUE (EXPENSE)

 

-102.619,99

-26.255,78

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

 

83.315,18

117.778,23

NON-OPERATING RESULT

 

-569,64

 

CONTRIBUTION/INCOME TAX

 

-18.681,90

 

 

----------------

----------------

----------------

NET PROFIT (LOSS)

 

64.063,64

117.778,23

 

MONTHLY SALES

 

  2012

 

 

 

---------------------

 

 

JANUARY

R$ 920.079,50

 

 

FEBRUARY

R$ 946.063,77

 

 

MARCH

R$ 1.076.220,82

 

 

APRIL

R$ 850.703,63

 

 

MAY

R$ 866.088,36

 

 

JUNE

R$ 658.698,49

 

 

JULY

R$ 659.751,52

 

 

AUGUST

 

 

 

SEPTEMBER

 

 

 

OCTOBER

 

 

 

NOVEMBER

 

 

 

DECEMBER

 

 

 

TOTAL

R$ 5.977.606,09

 

 

 

RATIOS:

31/12/2009

31/12/2008

31/12/2007

 

QUICK RATIO

,72

 

,58

 

1,61

 

CURRENT RATIO

1,11

 

,91

 

3,69

 

ACCOUNTS RECEIVABLE TURNOVER

 

 

6,10

TIMES

4,00

TIMES

DAYS' SALES IN RECEIVABLES

 

 

59,04

DAYS

90,04

DAYS

INVENTORY TURNOVER

 

 

5,21

TIMES

1,69

TIMES

ACCOUNTS PAYABLE PERIOD

 

 

88,91

DAYS

29,66

DAYS

RETURN ON ASSETS

 

 

1,08

TIMES

,43

TIMES

SALES TURNOVER ON NET EQUITY

 

 

-1,72

TIMES

-,58

TIMES

NET WORTH TIE-UP

-1,04

 

-,99

 

-1,03

 

INDEBTEDNESS

-2,92

 

-2,59

 

-,47

 

EQUITY RATIO

-52,10

%

-62,87

%

-73,35

%

WORKING CAPITAL RATIO

10,79

%

-9,19

%

268,74

%

GENERAL SOLVENCY

,66

 

,61

 

2,88

 

RETURN ON NET EQUITY

 

 

-1,94

%

-3,72

%

RETURN ON SALES (PROFIT MARGIN)

 

 

1,13

%

6,41

%

GROSS PROFIT MARGIN

 

 

41,32

%

45,16

%

OPERATIONAL RESULT

 

 

1,47

%

6,41

%

SALES TURNOVER ON LIABILITIES

 

 

2,90

TIMES

6,42

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 2,02

 - OFFICIAL RATE ON 25/10/2012

US$ 1,00 = R$ 1,74

 - OFFICIAL RATE ON 31/03/2009

US$ 1,00 = R$ 2,33

 - OFFICIAL RATE ON 31/12/2008

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW AN UNBALANCED FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS IS VERY HIGH DUE TO ITS NEGATIVE NET EQUITY AND THE LIQUIDITY IS LOW. THE PROFIT AND LOSS ACCOUNTS WAS NOT MADE AVAILABE.

 

IT IS WORTH TO COMMENT THAT DESPITE THE POSITIVE RESULTS SHOWED THE COMPANY UNTIL AUGUST 2007 WAS OPERATING UNDER THE SUPERVISION OF THE COURT AND ITS DEBTS KEEPS HIGHER THAN ITS CURRENT ASSETS, CONSEQUENTLY IT IS PROPER TO SAY THAT THE REAL SITUATION IS STILL UNFAVORABLE.

 

REMARKS:

 

A REQUEST FOR UPDATED FINANCIAL DATA HAS BEEN SENT TO THE COMPANY. PROVIDED THE DATA REQUESTED ARE RECEIVED FROM THE SUBJECT A COMPLEMENTARY REPORT WILL BE SENT TO YOUR ATTENTION.

 

REAL ESTATE:

 

   NOT AVAILABLE

 

VEHICLES:

 

   OWNED VEHICLES ARE VALUED AT R$ 18.000,00

 

 

 

 

MACHINES:

 

   OWNED MACHINES AND EQUIPMENTS ARE VALUED AT R$ 131.130,02

 

 

INSURANCE

 

NOT AVAILABLE.

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

 

BANCO SOFISA S/A

0001 / 11 3176-5645

 

BANCO SANTANDER (BRASIL) S/A

4258 / 11 7487-2247

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

ACTIVITIES COMMENTS

 

THE SUBJECT IS ENGAGED IN THE WHOLESALE, IMPORT AND TRADE OF PHARMACEUTICAL PRODUCTS.

 

IMPORT AND EXPORT:

 

   IMPORTS FROM:

INDIA, TAIWAN, CHINA, KOREA, GERMANY, ITALY, HOLLAND, SWITZERLAND, SPAIN, MEXICO AND UNITED STATES.

 

   EXPORTS TO:

NOT AVAILABLE.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

 

PHONE:

ALL CHEMISTRY DO BRASIL LTDA

 

11 5034-7040

DROGARIA ARAÚJO S/A

 

31 3270-5103

FARMÁCIA BUENOS AIRES LTDA

 

11 3825-8100

FARMÁCIA CENTRAL DE NOVA IGUAÇU

 

21 2668-4738

FARMÁCIA MORIMOTO LTDA

 

71 3379-7225

 

STAFF:

 

THE COMPANY HAS: 26 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT WAS ESTABLISHED IN 1992. DESPITE THE APPARENTLY NORMAL PAYMENT BEHAVIOR IT HAS A TRADE HISTORY BLEMISHED BY SEVERAL DETRIMENTAL FILES AND THE COMPANY IS CURRENTLY UNDER JUDICIAL RECOVERY.

 

OUR INVESTIGATION THROUGH THE PUBLIC RECORDS SHOWED SEVERAL DETRIMENTAL FILES REGISTERED AGAINST THE SUBJECT AND DUE TO THE HIGH NUMBER AND AMOUNT OF THE PROTESTED BILLS SHOWING SUBJECT HAS CURRENTLY A BLEMISHED REPUTATION AND NEGATIVE CREDITWORTHINESS.

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

CITY:

PHONE:

AB FARMOQUÍMICA LTDA

ANÁPOLIS/GO

11 3266-8622

ALPHATASTE INDUSTRIA E COMERCIO LTDA

JANDIRA/SP

11 4789-7133

AMBROSIFARMA COMÉRCIO IMPORTAÇÃO LTDA

SÃO PAULO/SP

11 5565-2929

ANIDRO DO BRASIL DESIDRATAÇÃO LTDA

BOTUCATU/SP

11 4193-2260

EXTRACAPS COMERCIAL LTDA

SÃO PAULO/SP

11 3274-5525

GÊNIX INDÚSTRIA FARMACÊUTICA LTDA

ANÁPOLIS/GO

0800-105-008

MILÊNIO EMBALAGENS LTDA

DIADEMA/SP

11 4067-2566

ODIN INDÚSTRIA E COMÉRCIO LTDA

SÃO PAULO/SP

11 3619-6444

OPÇÃO FENIX DISTR. INSUMOS FARMACÊUTICOS

SÃO PAULO/SP

11 3659-4268

PHARMASAIS DISTRIB E COM. ESP. FARMACÊUTICAS LTDA

TABULEIRO/AL

11 3806-1760

PURIFARMA DISTR. QUÍM. FARMACÊUTICA LTDA

SÃO PAULO/SP

11 3272-5600

QUIMER COMERCIAL LTDA

SÃO PAULO/SP

11 6955-8800

QUIMER COMERCIAL LTDA

SÃO PAULO/SP

11 2955-8800

RP SCHERER DO BRASIL ENCAPULAÇÕES LTDA

SOROCABA/SP

15 3235-3500

SANRISIL INDÚSTRIA E COMÉRCIO S/A

ITAQUAQUECETUBA/SP

11 4646-3600

SP FARMA LTDA

SÃO PAULO/SP

11 5091-3050

VALDEQUIMICA PRODUTOS QUÍMICOS LTDA

SÃO PAULO/SP

11 3721-1077

 

FOREIGN SUPPLIERS:

COUNTRY:

 

AARTI DRUGS LTDA

INDIA

 

ACETO CORPORATION

UNITED STATES

 

ALGRY QUÍMICA S. L

SPAIN

 

AXXO IM & EXPORT GMBH

GERMANY

 

CHEMICAL SOLUTION IND

KOREA

 

FARMABIOS S. P. A

ITALY

 

FERSINSA GIST BROCADES S/A

MEXICO

 

NUTRILIFE LLC

CHINA

 

SALZGITTER INTERNATIONAL GMBH

GERMANY

 

 

 

PAYMENT HISTORY:

 

01 SUPPLIER REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 1.463,00

 

AMOUNT OF INVOICES PAID: 1

TOTAL OF PROMPT PAYMENTS: 100%

HIGHEST INVOICE: R$ 1.463,00

HIGHEST CREDIT: R$ 1.463,00

 

 

FINAL OPINION

 

BASED ON THE GENERAL INFORMATION AVAILABLE WE ARE NOT ABLE TO RECOMMEND ANY BUSINESS WITH THE SUBJECT.

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.53.63

UK Pound

1

Rs.86.17

Euro

1

Rs.69.74

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.